PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to journals

Source

Scientia Pharmaceutica

2 developments in the corpus

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

NOV 4, 2026 · JOURNAL ARTICLE

Piceatannol as a Multitarget Modulator of Obesity-Associated Metabolic Dysfunction: From Molecular Mechanisms to Clinical Translation

Scientia Pharmaceutica

Background/Objectives: Obesity is a multifactorial chronic disease involving adipose tissue dysfunction, low-grade inflammation, oxidative stress, mitochondrial dysfunction, and in

SEP 4, 2026 · JOURNAL ARTICLE

The Role of Phenolic Compounds in NF-κB, Nrf2, and STAT3 Transcription Factors Regulation: Therapeutic Potential and Limitations in Cancer Treatment

Scientia Pharmaceutica

This is a narrative review synthesizing preclinical evidence on mechanisms of phenolic compounds in cancer models, raising questions about therapeutic potential rather than answering them with clinical trial data.

Hypothesis-GeneratingEirini Roungeri Athanasios A. Panagiotopoulos Kallirroi Dimiza

Study details

DesignNarrative review

InterventionPhenolic compounds and their derivatives (u…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support